Search Results - "Cerniglia, George"

Refine Results
  1. 1

    ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis by Dey, Souvik, Sayers, Carly M, Verginadis, Ioannis I, Lehman, Stacey L, Cheng, Yi, Cerniglia, George J, Tuttle, Stephen W, Feldman, Michael D, Zhang, Paul J L, Fuchs, Serge Y, Diehl, J Alan, Koumenis, Constantinos

    Published in The Journal of clinical investigation (01-07-2015)
    “…The integrated stress response (ISR) is a critical mediator of cancer cell survival, and targeting the ISR inhibits tumor progression. Here, we have shown that…”
    Get full text
    Journal Article
  2. 2

    Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 by Cerniglia, George J, Karar, Jayashree, Tyagi, Sonia, Christofidou-Solomidou, Melpo, Rengan, Ramesh, Koumenis, Constantinos, Maity, Amit

    Published in Molecular pharmacology (01-12-2012)
    “…We investigated the effect of 2-methyl-2-{4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]phenyl} propanenitrile (NVP-BEZ235)…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5

    Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia by Karar, Jayashree, Cerniglia, George J., Lindsten, Tullia, Koumenis, Constantinos, Maity, Amit

    Published in Cancer biology & therapy (01-09-2012)
    “…The PI3K/Akt pathway is activated in many cancers; therefore, we investigated NVP-BEZ235, a dual PI3K/mTOR inhibitor. BEZ235 was more potent than either the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms by PORE, Nabendu, ZIBIN JIANG, GUPTA, Anjali, CERNIGLIA, George, KAO, Gary D, MAITY, Amit

    Published in Cancer research (Chicago, Ill.) (15-03-2006)
    “…Epidermal growth factor receptor (EGFR) inhibitors can decrease vascular endothelial growth factor (VEGF) expression and tumor angiogenesis. In the current…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal Toxicity by Finnberg, Niklas K, Gokare, Prashanth, Navaraj, Arunasalam, Lang Kuhs, Krystle A, Cerniglia, George, Yagita, Hideo, Takeda, Kazuyoshi, Motoyama, Noboru, El-Deiry, Wafik S

    Published in Cancer research (Chicago, Ill.) (01-02-2016)
    “…The combination of TRAIL death receptor agonists and radiochemotherapy to treat advanced cancers continues to be investigated in clinical trials. We previously…”
    Get full text
    Journal Article
  10. 10

    Nelfinavir down-regulates hypoxia-Inducible factor 1α and VEGF expression and increases tumor oxygenation : Implications for radiotherapy by PORE, Nabendu, GUPTA, Anjali K, CERNIGLIA, George J, ZIBIN JIANG, BERNHARD, Eric J, EVANS, Sydney M, KOCH, Cameron J, HAHN, Stephen M, MAITY, Amit

    Published in Cancer research (Chicago, Ill.) (15-09-2006)
    “…Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt pathway can increase vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1α (HIF-1α)…”
    Get full text
    Journal Article
  11. 11

    The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response by Gupta, Anjali K., Li, Bin, Cerniglia, George J., Ahmed, Mona S., Hahn, Stephen M., Maity, Amit

    Published in Neoplasia (New York, N.Y.) (01-04-2007)
    “…HIV protease inhibitors (HPIs), which have been used to treat HIV patients since the mid 1990s, have been shown to downregulate the phosphatidylinositol…”
    Get full text
    Journal Article
  12. 12

    HIV protease inhibitors block akt signaling and radiosensitize tumor cells both in vitro and in vivo by GUPTA, Anjali K, CERNIGLIA, George J, MICK, Rosemarie, MCKENNA, W. Gillies, MUSCHEL, Ruth J

    Published in Cancer research (Chicago, Ill.) (15-09-2005)
    “…In tumor cells with mutations in epidermal growth factor receptor (SQ20B), H-Ras (T24), or K-Ras (MIAPACA2 and A549), the inhibition of Akt phosphorylation…”
    Get full text
    Journal Article
  13. 13

    Translational Upregulation of an Individual p21Cip1 Transcript Variant by GCN2 Regulates Cell Proliferation and Survival under Nutrient Stress by Lehman, Stacey L, Cerniglia, George J, Johannes, Gregg J, Ye, Jiangbin, Ryeom, Sandra, Koumenis, Constantinos

    Published in PLoS genetics (01-06-2015)
    “…Multiple transcripts encode for the cell cycle inhibitor p21(Cip1). These transcripts produce identical proteins but differ in their 5' untranslated regions…”
    Get full text
    Journal Article
  14. 14

    Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002 by Gupta, Anjali K, Cerniglia, George J, Mick, Rosemarie, Ahmed, Mona S, Bakanauskas, Vincent J, Muschel, Ruth J, McKenna, W Gillies

    “…Multiple genetic alterations such as in Ras or EGFR can result in sustained signaling through PI3K. Our previous experiments have shown that resistance to…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Validation and toxicity of PI3K/Akt pathway inhibition by HIV protease inhibitors in humans by P. Plastaras, John, Vapiwala, Neha, S. Ahmed, Mona, Gudonis, Deborah, J. Cerniglia, George, D. Feldman, Michael, Frank, Ian, K. Gupta, Anjali

    Published in Cancer biology & therapy (01-05-2008)
    “…PurposeActivation of the phosphatidylinositol 3-kinase/Akt pathway in tumors leads to radiation resistance, and inhibition of this pathway radiosensitizes…”
    Get full text
    Journal Article
  17. 17

    RhoB Is Required to Mediate Apoptosis in Neoplastically Transformed Cells after DNA Damage by Liu, Ai-xue, Cerniglia, George J., Bernhard, Eric J., Prendergast, George C.

    “…The effect of neoplastic transformation on the response to genotoxic stress is of significant clinical interest. In this study, we offer genetic evidence that…”
    Get full text
    Journal Article
  18. 18

    Inhibition of Centrosome Separation after DNA Damage: A Role for Nek2 by Fletcher, Lynda, Cerniglia, George J., Nigg, Erich A., Yen, Tim J., Muschel, Ruth J.

    Published in Radiation research (01-08-2004)
    “…Fletcher, L., Cerniglia, G. J., Nigg, E. A., Yen, T. J. and Muschel, R. J. Inhibition of Centrosome Separation after DNA Damage: A Role for Nek2. Radiat. Res…”
    Get full text
    Journal Article
  19. 19

    HIV Protease Inhibitors Decrease VEGF/HIF-1α Expression and Angiogenesis in Glioblastoma Cells by Pore, Nabendu, Gupta, Anjali K., Cerniglia, George J., Maity, Amit

    Published in Neoplasia (New York, N.Y.) (01-11-2006)
    “…Glioblastomas are malignant brain tumors that are rarely curable, even with aggressive therapy (surgery, chemotherapy, radiation). Glioblastomas frequently…”
    Get full text
    Journal Article
  20. 20

    Live cell imaging reveals distinct roles in cell cycle regulation for Nek2A and Nek2B by Fletcher, Lynda, Cerniglia, George J., Yen, Tim J., Muschel, Ruth J.

    Published in Biochimica et biophysica acta (30-06-2005)
    “…Two splice variants of Nek2 kinase, a member of the NIMA-related family, have been identified as Nek2A and Nek2B. Nek2A regulates centrosome disjunction,…”
    Get full text
    Journal Article